Europe Amniotic Products Market, Size, Segment and Growth by Forecast Period: 2023-2028
The Europe amniotic products market is expected to grow from US$ 362.61 million in 2022 to US$ 582.01 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.
📚Download Full PDF Sample
Copy of Market Report @
https://wwcw.businessmarketinsights.com/sample/BMIRE00026176
Demand for wound care biologics, such as amniotic membranes,
has increased significantly due to the high prevalence of burn wounds. In 2019,
a total of 8,378,122 new burns cases were recorded (95% UI,
10,363,109–6,531,887 cases). Burn fatality rates have been declining in many
high-income nations, but child burn deaths are now ~7 times greater in low- and
middle-income countries than in high-income countries. From 1990 to 2019, the
burden of burns declined progressively and was thought to be reduced in most
regions. Moreover, according to the Children's Burn Trust and the British Burn
Association, 625 children are admitted to an NHS Burns Service each month due
to burn or scald injuries. In 2017, the NHS's burns and scalds services treated
more than 15,000 patients with these injuries, with a total cost of more than
US$ 24.94 million (i.e., GBP 20 million). Also, out of these patients, more
than 40 cases were extremely serious, with treatment procedures costing more
than US$ 118,455.50 (GBP 95,000) per person. Biologic materials are now used in
various surgical procedures due to recent tissue harvesting, screening, and
banking advancements. Burns, nerve regeneration, soft tissue reconstructive
surgeries, ophthalmic surgeries, and diabetic foot ulcer surgeries are among
the applications for amniotic membranes. Amniotic membrane has been
demonstrated to improve healing rates, reduce infection rates, shorten hospital
stays, and reduce the number of dressing changes required in burn patients.
Therefore, it has a lot of scopes to improve outcomes and save money. The
amniotic membrane is helpful in treating chronic wounds, such as diabetic foot
ulcers. It also holds tremendous potential for the treatment of donor skin
graft sites, wounds treated with skin grafts, and partial thickness burns.
Thus, increasing burn cases are driving the amniotic product market in Europe.
With the new features and technologies, vendors can attract
new customers and expand their footprints in emerging markets. This factor is
likely to drive the Europe amniotic products market. The Europe
amniotic products market is expected to grow at a good CAGR during the
forecast period.
Europe Amniotic Products Strategic Insights
Strategic insights for the Europe Amniotic Products provides
data-driven analysis of the industry landscape, including current trends, key
players, and regional nuances. These insights offer actionable recommendations,
enabling readers to differentiate themselves from competitors by identifying
untapped segments or developing unique value propositions. Leveraging data
analytics, these insights help industry players anticipate the market shifts,
whether investors, manufacturers, or other stakeholders. A future-oriented
perspective is essential, helping stakeholders anticipate market shifts and
position themselves for long-term success in this dynamic region. Ultimately,
effective strategic insights empower readers to make informed decisions that
drive profitability and achieve their business objectives within the market.
Market leaders and key company profiles
Integra LifeSciences
Katena Products.
Inc.
MiMedx
NuVision
Biotherapies Ltd
Organogenesis, Inc.
Sanuwave and
Sanuwave Health, Inc.
Smith & Nephew
Stryker
Europe Amniotic Products Regional Insights
The geographic scope of the Europe Amniotic Products refers
to the specific areas in which a business operates and competes. Understanding
local distinctions, such as diverse consumer preferences (e.g., demand for
specific plug types or battery backup durations), varying economic conditions,
and regulatory environments, is crucial for tailoring strategies to specific
markets. Businesses can expand their reach by identifying underserved areas or
adapting their offerings to meet local demands. A clear market focus allows for
more effective resource allocation, targeted marketing campaigns, and better
positioning against local competitors, ultimately driving growth in those
targeted areas.
Europe Amniotic Products Market Segmentation
The Europe amniotic products market is bifurcated based on
type, application, end user and country. Based on type, the market is segmented
into amniotic membranes, and amniotic suspensions. The amniotic membranes
segment dominated the market in 2022 and is expected to be fastest growing
during forecast period. Based on application, the market is segmented into
wound care, orthopedics, ophthalmology, and other applications. The wound care
segment dominated the market in 2022 and orthopedics segment is expected to be
fastest growing during forecast period. Based on end user, the market is
segmented into hospitals and clinics, ambulatory surgical centers, and other
end users. The hospitals and clinics segment dominated the market in 2022 and
ambulatory surgical centers segment is expected to be fastest growing during
forecast period. Based on country, the Europe amniotic products market is
segmented into the UK, Germany, France, Italy, Spain, and Rest of Europe.
Integra LifeSciences; Katena Products. Inc.; MiMedx;
NuVision Biotherapies Ltd; Organogenesis, Inc.; Sanuwave and Sanuwave Health,
Inc.; Smith & Nephew; and Stryker are among the leading companies in the
Europe amniotic products market.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author's Bio
Akshay
Senior Market Research Expert at Business Market Insights
Comments
Post a Comment